Drug Delivery Systems from Nose to Brain

被引:57
作者
Misra, Ambikanandan [1 ]
Kher, Gitanjali [1 ]
机构
[1] Maharaja Sayajirao Univ Baroda, Dept Pharm, Fac Engn & Technol, Kalabhavan 390001, Vadodara, India
关键词
Nasal drug delivery; brain; drug targeting; delivery techniques; delivery systems and devices; CENTRAL-NERVOUS-SYSTEM; NASAL ABSORPTION PROMOTERS; ACID MIXED MICELLES; INTRANASAL MUCOADHESIVE MICROEMULSIONS; WATER-SOLUBLE COMPOUNDS; PEG-PLA NANOPARTICLES; DEEP CERVICAL LYMPH; CEREBROSPINAL-FLUID; CHITOSAN NANOPARTICLES; IN-VITRO;
D O I
10.2174/138920112803341752
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The treatment of brain disorders is particularly challenging due to the presence of a variety of formidable obstacles to deliver drugs selectively and effectively to the brain. Blood-brain-barrier (BBB) constitutes the major obstacle to the uptake of drugs into the brain following systemic administration. Intranasal delivery offers a non-invasive and convenient method to bypass the BBB and delivery of therapeutics directly to the brain. The review discusses the potential of intranasal route to deliver drugs to the brain, the mechanisms and pathways of direct nose to brain drug transport, the various factors influencing transnasal drug absorption, the conventional and novel intranasal drug delivery systems, the various intranasal drug delivery techniques and devices, and examples of brain drug transport that have been feasible in treating various brain disorders. Moreover, products on the market, investigational drugs, and the author's perceptions about the prospect of intranasal delivery for treating brain disorders are also been discussed.
引用
收藏
页码:2355 / 2379
页数:25
相关论文
共 256 条
[1]  
Abd El-Shafy M, 2000, J DRUG TARGET, V7, P355
[2]  
Abe K, 1995, CHEM PHARM BULL, V43, P2232
[3]  
Agarwal Varsha, 1999, Indian Journal of Experimental Biology, V37, P6
[4]   PREPARATION AND EVALUATION OF PROLIPOSOMES CONTAINING PROPRANOLOL HYDROCHLORIDE [J].
AHN, BN ;
KIM, SK ;
SHIM, CK .
JOURNAL OF MICROENCAPSULATION, 1995, 12 (04) :363-375
[5]   N-Trimethyl chitosan (TMC) nanoparticles loaded with influenza subunit antigen for intranasal vaccination:: Biological properties and immunogenicity in a mouse model [J].
Amidi, Maryam ;
Romeijn, Stefan G. ;
Verhoef, J. Coos ;
Junginger, Hans E. ;
Bungener, Laura ;
Huckriede, Anke ;
Crommelin, Daan J. A. ;
Jiskoot, Wim .
VACCINE, 2007, 25 (01) :144-153
[6]  
[Anonymous], 1966, HEALTH PHYS, V12, P173
[7]   DISTRIBUTION AND REMOVAL OF HUMAN-SERUM ALBUMIN TC-99M 99M INSTILLED INTRANASALLY [J].
AOKI, FY ;
CRAWLEY, JCW .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1976, 3 (05) :869-878
[8]   Permeability issues in nasal drug delivery [J].
Arora, P ;
Sharma, S ;
Garg, S .
DRUG DISCOVERY TODAY, 2002, 7 (18) :967-975
[9]  
Aurora J., 2002, Drug Deliv Technol, V2, P1
[10]   The potential of nasal application for delivery to the central brain - a microdialysis study of fluorescein in rats [J].
Bagger, MA ;
Bechgaard, E .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2004, 21 (2-3) :235-242